Active, Not Recruiting Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension NCT06515678 Conditions Adjuvant Bevacizumab, Adnexal Diseases, Antiangiogenic-Associated Hypertension, +18 more Locations Institut Curie — Paris, France Pitié-Salpêtrière — Paris, France View Trial Details
